Gynecological Devices Market Analysis, Size, Trends | United States | 2023-2029 | MedSuite | Includes: Gynecological Endoscope Devices, Endometrial Ablation Devices, Morcellator Device Market and 7 more.

  • Year: 2023
  • Scope: 10 Years
  • Region: United States
  • Pages: 332
  • Published Date: 2023-07-05
  • Type: MedSuite

Product Description

In 2022, the U.S. gynecological devices market size was valued at approximately $1.3 billion, with nearly 3 million gynecological procedures performed every year. Throughout this medical device market research, we analyzed over 70 Gynecological Device companies across the United States and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

The full report suite on the U.S. market for gynecological devices includes assisted reproduction technology devices, global endometrial ablation, uterine fibroid embolization devices, gynecological endoscopes, gynecological resection electrodes, morcellators, pelvic floor electrical stimulation devices, fluid management devices, pelvic organ prolapse repair devices and
hysterosalpingography (HSG) catheters.

DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Gynecological Procedure Volumes
  • Forecasts Until 2029, and Historical Data to 2019
  • Market Drivers & Limiters for Each Gynecological Device market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

U.S. Gynecological Devices Market Insights

As companies compete to capture market share through smart pricing strategies, the ASP in each of the market segments will decline. This downward trend in pricing may entice purchasers who are exploring alternative solutions, prompting providers of alternative gynecological devices to further reduce their prices in a cross-category price competition. In recent years, numerous clinics
have joined purchasing groups, leading to enhanced leverage for the buyers. Consequently, sellers face intensified pressure to offer their gynecological devices at competitive prices in order to secure broader market access.

Gynecology Devices Market

One major trend in the U.S. market for gynecological devices is to avoid, when the condition permits, the need of hysterectomies. Fibroids and endometriosis affect a significant proportion of women in the United States, with 20-25% of reproductive-age women and 11% of women between 15 and 44 being affected, according to the U.S. National Institutes of Health (NIH). Common treatment options for these conditions include birth control, surgery and, in severe cases, hysterectomy, which is associated with invasiveness of the procedure and lengthy recovery periods. To avoid the need for hysterectomy, physicians are increasingly turning to minimally
invasive treatments such as hysteroscopic surgeries, uterine artery embolization and endometrial ablation. These procedures offer less invasiveness, faster recovery periods and have become preferred alternatives for patients.

U.S. Gynecological Devices Market Share Insights

The total gynecological device market in the U.S. was dominated by Hologic, Medtronic, Cooper Surgical and Minerva Surgical. Collectively, these competitors accounted for over 50% of the overall market share.

Hologic led the market with a dominant share, which was achieved through its products in the global endometrial ablation, hysteroscopic morcellators for mechanical uterine tissue removal, endoscopes and fluid management device markets.

In 2022, Medtronic was the second-leading competitor in the U.S. gynecological market. The company competes in the morcellator and in the fluid management device market. Medtronic’s TruClear™ Hysteroscopic morcellator earned the company a large share of the morcellator device market in the United States.

Minerva Surgical was the fourth-leading competitor in the U.S. gynecological market. The company competes in the global endometrial ablation, gynecological endoscope, morcellator, and fluid management markets. In 2020, Minerva Surgical acquired the intrauterine portfolio from Boston Scientific.

Cooper Surgical was the leading competitor in the assisted reproduction technology device, gynecological endoscope, and HSG catheter segments, gaining its third-leading share in the gynecological device market in the U.S.

Segments Covered

  • Assisted reproduction technology devices
  • Global endometrial ablation
  • Uterine fibroid embolization devices
  • Gynecological endoscopes
  • Gynecological resection electrodes
  • Morcellator devices
  • Pelvic floor electrical stimulation devices
  • Fluid management devices
  • Pelvic organ prolapse repair devices
  • Hysterosalpingography (HSG) catheters

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

FREE Sample Report

TABLE of CONTENTS
TABLE of CONTENTSi
List of Figuresxi
List of Chartsxviii
executive summary1
U.S. Gynecological Device Market Overview1
Competitive Analysis4
Market Trends8
Market Developments10
Procedure Numbers12
Procedure Codes Investigated14
Markets Included15
Key Report Updates17
Version History18
research methodology19
Step 1: Project Initiation & Team Selection19
Step 2: Prepare Data Systems and Perform Secondary Research22
Step 3: Preparation for Interviews & Questionnaire Design24
Step 4: Performing Primary Research25
Step 5: Research Analysis: Establishing Baseline Estimates27
Step 6: Market Forecast and Analysis28
Step 7: Identify Strategic Opportunities30
Step 8: Final Review and Market Release31
Step 9: Customer Feedback and Market Monitoring32
impact of covid-19 on the U.S. Gynecological device Market33
2.1 Introduction33
2.2 Analysis By Market Segment35
2.2.1 Best Case Scenario35
2.2.2 Base Case Scenario37
2.2.3 Worst Case Scenario39
Disease Overview42
3.1 Basic Anatomy42
3.2 Disease Treatment and Diagnostic44
3.2.1 Introduction44
3.2.2 General Diagnostics45
3.2.3 Assisted Reproduction Technologies (ART)46
3.2.3.1 ART Costs46
3.2.4 Abnormal Uterine Bleeding49
3.2.5 Gynecologic Cancer and Tumors in Reproductive System50
3.2.6 Female Sterilization51
3.2.7 Urinary Incontinence51
3.2.8 Pelvic Organ Prolapse52
3.3 Patient Demographics54
3.3.1 Assisted Reproduction Technologies (ART)54
3.3.2 Abnormal Uterine Bleeding54
3.3.3 Gynecologic Cancer and Tumors in Reproductive System55
3.3.4 Pelvic Organ Prolapse56
3.3.5 Endometriosis57
3.3.6 Polycystic ovary syndrome57
3.3.7 Female Sterilization57
Product Assessment59
4.1 Introduction59
4.2 Product Portfolios60
4.2.1 Assisted Reproduction Technology Device60
4.2.2 Global Endometrial Ablation Market63
4.2.3 Uterine Fibroid Embolization Device64
4.2.4 Gynecological Endoscopes65
4.2.5 Gynecological Resection Electrode67
4.2.6 Gynecological Morcellators69
4.2.7 Pelvic Floor Electrical Stimulation Device71
4.2.8 Fluid Management Device73
4.2.9 Pelvic Organ Prolapse Repair Device74
4.2.10 HSG Catheter75
4.2.11 Uterine Manipulators77
4.3 Regulatory Issues and Recalls78
4.3.1 Assisted Reproduction Technology Device Market78
4.3.2 Gynecological Endoscope Market80
4.3.3 Gynecological Resection Electrode Market81
4.3.4 Morcellator Market82
4.3.5 Fluid Management Device Market83
4.3.6 Pelvic Organ Prolapse Repair Device Market84
4.3.7 HSG Catheter Market86
4.3.8 Uterine Manipulator Market87
4.4 Clinical Trials88
4.4.1 Assisted Reproduction Technology Device89
4.4.2 Global Endometrial Ablation93
4.4.3 Uterine Fibroid Embolization Device94
4.4.4 Gynecological Endoscopes96
4.4.5 Gynecological Morcellators97
4.4.6 Pelvic Floor Electrical Stimulation Device99
4.4.7 Pelvic Organ Prolapse Repair Device102
4.4.8 Uterine Manipulators105
U.S. Gynecological Device Market Overview107
5.1 Introduction107
5.2 Market Overview and Trend Analysis108
5.3 Drivers and Limiters113
5.3.1 Market Drivers113
5.3.2 Market Limiters114
5.4 Competitive Market Share Analysis116
5.5 Mergers and Acquisitions126
5.6 Company Profiles128
5.6.1 Boston Scientific128
5.6.2 Coloplast129
5.6.3 Cooper Surgical130
5.6.4 Hologic131
5.6.5 Laborie Medical132
5.6.6 Medtronic133
5.6.7 Merit Medical Systems134
5.6.8 Minerva Surgical135
5.6.9 Olympus136
5.6.10 Richard Wolf137
5.7 SWOT Analysis138
5.7.1 Boston Scientific139
5.7.2 Coloplast140
5.7.3 Cooper Surgical141
5.7.4 Hologic142
5.7.5 Laborie Medical143
5.7.6 Medtronic144
5.7.7 Merit Medical Systems145
5.7.8 Minerva Surgical146
5.7.9 Olympus147
5.7.10 Richard Wolf148
procedure Numbers149
6.1 Introduction149
6.1.1 Ovarian Cancer Incidence149
6.1.2 Pelvic Screens151
6.2 Procedures Number Overview153
6.2.1 Fallopian Tube Procedures157
6.2.2 Assisted Reproduction Technology Procedures by Type158
6.2.3 Cervical Repair and Biopsy Procedures159
6.2.4 Global Endometrial Ablation Procedures160
6.2.4.1 Thermal Ablation Procedures160
6.2.4.2 Hydrothermal Ablation Procedures160
6.2.4.3 Radiofrequency Ablation Procedures160
6.2.4.4 Cryoablation Procedures160
6.2.5 Uterine Fibroid Embolization Procedures by Type162
6.2.6 Gynecological Endoscope Procedures163
6.2.7 Morcellation Procedures165
6.2.8 Vaginal Procedures167
6.2.9 Pelvic Organ Prolapse Procedures by Type168
6.2.10 HSG Catheter Procedures by Type170
6.2.11 Myomectomy Procedures171
6.2.12 Hysterectomy Procedures172
6.2.12.1 Hysterectomy Procedures by Type172
6.2.12.1 Hysterectomy Procedures by Approach174
Assisted Reproduction Technology Device Market176
7.1 Introduction176
7.1.1 Media177
7.1.2 Vitrification177
7.2 Market Overview178
7.3 Market Analysis and Forecast181
7.3.1 Oocyte Retrieval Needle Market181
7.3.2 Micropipette Market182
7.3.2.1 Flexible Pipette Market184
7.3.2.2 ICSI Pipette Market185
7.3.3 Embryo Transfer Catheter Market186
7.3.4 Reproduction Media Market187
7.3.4.1 Culture Media Market190
7.3.4.2 Sperm Preparation Media Market191
7.3.4.3 Manipulation Media Market192
7.3.4.4 Freeze/Thaw Media Market193
7.4 Drivers and Limiters194
7.4.1 Market Drivers194
7.4.2 Market Limiters195
7.5 Competitive Market Share Analysis196
Global Endometrial Ablation Market199
8.1 Introduction199
8.1.1 Hydrothermal Ablation199
8.1.2 Radiofrequency Ablation199
8.1.3 Cryoablation200
8.1.4 Roller-Ball Ablation200
8.2 Market Overview201
8.3 Market Analysis and Forecast204
8.3.1 Total Global Endometrial Ablation Market204
8.3.2 Thermal Ablation Device Market205
8.3.3 Hydrothermal Ablation Device Market206
8.3.4 Radiofrequency Ablation Device Market207
8.3.5 Cryoablation Device Market208
8.4 Drivers and Limiters209
8.4.1 Market Drivers209
8.4.2 Market Limiters210
8.5 Competitive Market Share Analysis211
Uterine Fibroid Embolization Device Market214
9.1 Introduction214
9.1.1 Microspheres215
9.1.2 Polyvinyl Alcohol Particles215
9.1.3 Drug-Eluting Particles215
9.2 Market Overview216
9.3 Market Analysis and Forecast219
9.3.1 Microsphere Market219
9.3.2 PVA Particle Market220
9.4 Drivers and Limiters221
9.4.1 Market Drivers221
9.4.2 Market Limiters221
9.5 Competitive Market Share Analysis223
Gynecological Endoscope Market226
10.1 Introduction226
10.1.1 Hysteroscopes226
10.1.2 Colposcopes227
10.1.3 Resectoscopes227
10.2 Market Overview229
10.3 Market Analysis and Forecast231
10.3.1 Hysteroscope Market231
10.3.1.1 Reusable Hysteroscope Market233
10.3.1.2 Reusable Rigid Hysteroscope Market234
10.3.1.3 Reusable Flexible Hysteroscope Market235
10.3.1.3.1 Video Flexible Hysteroscope Market237
10.3.1.3.2 Fiber Flexible Hysteroscope Market238
10.3.1.4 Disposable Hysteroscope Market239
10.3.2 Colposcope Market240
10.3.2.1 Video Colposcope Market242
10.3.2.2 Non-Video Colposcope Market243
10.3.3 Resectoscope Market244
10.4 Drivers and Limiters245
10.4.1 Market Drivers245
10.4.2 Market Limiters246
10.5 Competitive Market Share Analysis247
Gynecological Resection Electrode Market254
11.1 Introduction254
11.2 Market Overview255
11.3 Market Analysis and Forecast258
11.3.1 Monopolar Loop Electrode Market258
11.3.2 Bipolar Loop Electrode Market259
11.4 Drivers and Limiters260
11.4.1 Market Drivers260
11.4.2 Market Limiters260
11.5 Competitive Market Share Analysis262
Morcellator Market265
12.1 Introduction265
12.2 Market Analysis and Forecast267
12.2.1 Laparoscopic Morcellator Market269
12.2.2 Hysteroscopic Morcellator Market271
12.3 Drivers and Limiters273
12.3.1 Market Drivers273
12.3.2 Market Limiters273
12.4 Competitive Market Share Analysis275
Pelvic Floor Electrical Stimulation Device Market278
13.1 Introduction278
13.2 Market Overview280
13.3 Market Analysis and Forecast283
13.3.1 Home-Based PFES Device Market283
13.3.2 Office-Based PFES Device Market285
13.4 Drivers and Limiters286
13.4.1 Market Drivers286
13.4.2 Market Limiters286
13.5 Competitive Market Share Analysis288
Fluid Management Device MarkeT292
14.1 Introduction292
14.2 Market Overview293
14.3 Market Analysis and Forecast296
14.3.1 Fluid Management Equipment Market296
14.3.2 Fluid Management Tubing Market297
14.4 Drivers and Limiters298
14.4.1 Market Drivers298
14.4.2 Market Limiters298
14.5 Competitive Market Share Analysis300
Pelvic Organ Prolapse Repair Device Market303
15.1 Introduction303
15.2 Market Overview305
15.3 Market Analysis and Forecast308
15.3.1 Transvaginal Mesh Market308
15.3.2 Sacrocolpopexy Mesh Market309
15.4 Drivers and Limiters310
15.4.1 Market Drivers310
15.4.2 Market Limiters310
15.5 Competitive Market Share Analysis312
HSG Catheter Market315
16.1 Introduction315
16.2 Market Analysis and Forecast316
16.3 Drivers and Limiters319
16.3.1 Market Drivers319
16.3.2 Market Limiters319
16.4 Competitive Market Share Analysis320
Appendix: Uterine Manipulator market324
17.1 Introduction324
17.2 Market Analysis and Forecast325
17.3 Drivers and Limiters327
17.3.1 Market Drivers327
17.3.2 Market Limiters327
17.4 Competitive Market Share Analysis328
Abbreviations331
The Gynecological Devices Market Report Suite| United States | 2023 - 2029 | MedSuite includes analysis on the following companies currently active in this market:
AcuVuAdler Instrument
Applied MedicalArtisan Medical
ARTS MediaAthena Feminine Technology
Atlantic TherapeuticsBD
Biop MedicalBioteque America
Blue EndoCaldera Medical
CeloNova BioSciencesChannel Medsystems
ConMedCook Medical
Corinth MedTechCryoLogic
Donne Vie Medical TechnologyEdan Instruments
EthiconEspiner Medical
FemDx MedsystemsFujifilm
Genea BiomedxGynecare Innovation System
Gynex CorporationGyrus Medical
Hadleigh Health TechnologiesHamilton Thorne Incorporated
Hayden MedicalHysterovue
IllumigynInVitroCare
IVFStoreKarl Storz
K-fitKitazato USA
Kronner MedicalLina Medical
Lutech IndustriesMcKesson Medical-Surgical
MedGynMeditrina
Mermaid MedicalMobileODT
Monarch Medical ProductsMPM Medical Supply
NiproOlympus
Peters SurgicalRedi-tech Medical Products
RenoviaRocket Medical
Schoelly FiberopticSeiler Medical
Shenzhen Vita Vitro BiotechSonocath
STI Medical SystemsStrauss Surgical
StrykerSunlight Medical
TensCareThomas Medical
TriSalus Life SciencesUNICO
Utah MedicalVarian
VitrolifeVitromed
Win HealthZ&Z Medical
Zhejiang Horizon Medical TechnologyZynex
MedtronicHologic
VarianKarl Storz
Richard WolfInControl Medical
The Prometheus GroupLaborie
Merit MedicalMinerva Surgical
Cooper SurgicalColoplast
List of Charts
Chart 1‑1: Gynecological Device Market Value, U.S., 2019 – 20293
Chart 1‑2: Gynecological Device Market Overview, U.S., 2022 & 20293
Chart 2‑1: Multi-Scenario Gynecological Device Market Forecast, U.S., 2019 – 2029 (US$M)41
Chart 5‑1: Gynecological Device Market by Segment, U.S., 2019 – 2029112
Chart 5‑2: Leading Competitors, Gynecological Device Market, U.S., 2022125
Chart 6‑1: Gynecological Procedures by Type, U.S., 2019 – 2029156
Chart 7‑1: Assisted Reproduction Technology Device Market by Segment, U.S., 2019 – 2029180
Chart 7‑2: Leading Competitors, Assisted Reproduction Technology Device Market, U.S., 2022198
Chart 8‑1: Global Endometrial Ablation Market by Segment, U.S., 2019 – 2029203
Chart 8‑2: Leading Competitors, Global Endometrial Ablation Market, U.S., 2022213
Chart 9‑1: Uterine Fibroid Embolization Device Market by Segment, U.S., 2019 – 2029218
Chart 9‑2: Leading Competitors, Uterine Fibroid Embolization Device Market, U.S., 2022225
Chart 10‑1: Gynecological Endoscope Market by Segment, U.S., 2019 – 2029230
Chart 10‑2: Leading Competitors, Hysteroscope Market, U.S., 2022253
Chart 11‑1: Gynecological Electrosurgery Market, U.S., 2019 – 2029257
Chart 11‑2: Leading Competitors, Gynecological Resection Device Market, U.S., 2022264
Chart 12‑1: Gynecological Morcellator Market, U.S., 2019 – 2029268
Chart 12‑2: Leading Competitors, Morcellator Market, U.S., 2022277
Chart 13‑1: Pelvic Floor Electrical Stimulation Device Market by Segment, U.S., 2019 – 2029282
Chart 13‑2: Leading Competitors, Pelvic Floor Electrical Stimulation Device Market, U.S., 2022291
Chart 14‑1: Fluid Management Device Market by Segment, U.S., 2019 – 2029295
Chart 14‑2: Leading Competitors, Fluid Management Device Market, U.S., 2022302
Chart 15‑1: Pelvic Organ Prolapse Repair Device Market by Segment, U.S., 2019 – 2029307
Chart 15‑2: Leading Competitors, Pelvic Organ Prolapse Repair Device Market, U.S., 2022314
Chart 16‑1: HSG Catheter Market by segment, U.S., 2019 – 2029318
Chart 16‑2: Leading Competitors, HSG Catheter Market, U.S., 2022323
Chart 17‑1: Uterine Manipulator Market, U.S., 2019 – 2029326
Chart 17‑2: Leading Competitors, Uterine Manipulator Market, U.S., 2022330
List of Figures
Figure 1‑1: Gynecological Device Market Share Ranking by Segment, U.S., 2022 (1 of 2)5
Figure 1‑2: Gynecological Device Market Share Ranking by Segment, U.S., 2022 (2 of 2)5
Figure 1‑3: Companies Researched in This Report (1 of 2)6
Figure 1‑4: Companies Researched in This Report (2 of 2)7
Figure 1‑5: Factors Impacting the Gynecological Device Market by Segment, U.S. (1 of 2)8
Figure 1‑6: Factors Impacting the Gynecological Device Market by Segment, U.S. (2 of 2)9
Figure 1‑7: Recent Events in the Gynecological Device Market, U.S., 2019 – 2023 (1 of 2)10
Figure 1‑8: Recent Events in the Gynecological Device Market, U.S., 2019 – 2023 (2 of 2)11
Figure 1‑9: Gynecological Device Procedures Covered (1 of 2)12
Figure 1‑10: Gynecological Device Procedures Covered (2 of 2)13
Figure 1‑11: Procedure Codes Investigated14
Figure 1‑12: Gynecological Device Markets Covered (1 of 2)15
Figure 1‑13: Gynecological Device Markets Covered (2 of 2)16
Figure 1‑14: Key Report Updates17
Figure 1‑15: Version History18
Figure 2‑1: Gynecological Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 2)35
Figure 2‑2: Gynecological Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 2)36
Figure 2‑3: Gynecological Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 2)37
Figure 2‑4: Gynecological Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 2)38
Figure 2‑5: Gynecological Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 2)39
Figure 2‑6: Gynecological Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 2)40
Figure 3‑1: Gynecological Disease Overview44
Figure 3‑2: ART Procedure Availability Overview48
Figure 3‑3: Female Sterilization Estimation58
Figure 4‑1: Assisted Reproduction Technology Device by Company (1 of 2)61
Figure 4‑2: Assisted Reproduction Technology Device by Company (2 of 2)62
Figure 4‑3: Global Endometrial Ablation Market by Company63
Figure 4‑4: Uterine Fibroid Embolization Device Market by Company64
Figure 4‑5: Gynecological Endoscope Market by Company (1 of 2)65
Figure 4‑6: Gynecological Endoscope Market by Company (2 of 2)66
Figure 4‑7: Gynecological Resection Electrode Market by Company68
Figure 4‑8: Morcellator Market by Company70
Figure 4‑9: Pelvic Floor Electrical Stimulation Device Market by Company72
Figure 4‑10: Fluid Management Device Market by Company73
Figure 4‑11: Pelvic Organ Prolapse Repair Device Market by Company74
Figure 4‑12: HSG Catheter Market by Company76
Figure 4‑13: Uterine Manipulator Market by Company77
Figure 4‑14: Class 2 Device Recall BIOPSY MEDIUM78
Figure 4‑15: Class 2 Device Recall LifeGlobal Fast Freeze Thawing Kit78
Figure 4‑16: Class 2 Device Recall Vitrification Freeze Kit78
Figure 4‑17: Class 2 Device Recall MediCult Vitrification Cooling Media79
Figure 4‑18: Class 3 Device Recall79
Figure 4‑19: Class 2 Device Recall Guardia Access Nano Embryo Transfer Catheter79
Figure 4‑20: Class 2 Device Recall Embryo Transfer Catheters/Sets79
Figure 4‑21: Class 2 Device Recall Advanced Endosee Cannula80
Figure 4‑22: Class 2 Device Recall HF Resection Electrodes81
Figure 4‑23: Class 2 Device Recall Covidien TruClear Hysteroscopic Tissue Removal System82
Figure 4‑24: Class 2 Device Recall PneumoLiner82
Figure 4‑25: Class 2 Device Recall HysteroLux" Fluid Management System83
Figure 4‑26: Class 2 Device Recall Aquilex Fluid Control System Component: Bag Deflector83
Figure 4‑27: Class 2 Device Recall Colpassist Vaginal Positioning Device84
Figure 4‑28: Class 2 Device Recall Upsylon YMesh Kit with Colpassist Vaginal Positioning Device84
Figure 4‑29: Class 2 Device Recall VERITAS Collagen Matrix84
Figure 4‑30: Class 2 Device Recall Uphold Vaginal Support System84
Figure 4‑31: Class 2 Device Recall Posterior LITE w/ Capio SLIM85
Figure 4‑32: Class 2 Device Recall PFR Kit Pinnacle85
Figure 4‑33: Class 2 Device Recall McKesson86
Figure 4‑34: Class 2 Device Recall Cannula, Manipulator/Injector, Uterine87
Figure 4‑35: Class 2 Device Recall Advincula Delineator87
Figure 4‑36: The Impact of Past Coronavirus Disease 19 (COVID-19) Infection on the Live Birth Rates of Frozen Embryo Transfer Cycles89
Figure 4‑37: Impact of pH Values of the Embryo Culture Medium on Success of In Vitro Fertilization (IVF) (ACIDOFIV)89
Figure 4‑38: Assessment of Embryo Viability and Re-expansion After Thawing in Blastocyst Stage Embryos89
Figure 4‑39: Heated and Non Heated Ovarian Aspiration Needle Protocol90
Figure 4‑40: Fresh Vs Frozen Surgical Sperm in IVF90
Figure 4‑41: Comparing Two Types of Needle for Oocytes Retrieval (NEEDLE)90
Figure 4‑42: Comparison of Two Embryo Transfer Catheters in Patients Undergoing in Vitro Fertilization and Embryo Transfer91
Figure 4‑43: Male Fertility and Sperm Cryopreservation91
Figure 4‑44: Embryo Transfer with Self-spent Culture Medium91
Figure 4‑45: EmbryoGlue as an Embryo Transfer Medium92
Figure 4‑46: Influence of Post-thaw Embryo Culture Interval on Assisted Reproduction Success Rates92
Figure 4‑47: NovaSure Study: Endometrial Ablation in Women with Heavy Menstrual Bleeding (RAMBOS)93
Figure 4‑48: Pregnancy Outcome Following Global Fibroid Ablation Using the Acessa™ System93
Figure 4‑49: Spherical Gelfoam Versus Tri-acryl Microsphere for Uterine Artery Embolization for Symptomatic Fibroids94
Figure 4‑50: UA Versus UAE in Treatment of Fibroids94
Figure 4‑51: Satisfaction of Patients with Trans-Arterial Radial Access: Quality of Life in Uterine Fibroid Embolization Trial (SPARQLE)95
Figure 4‑52: A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery96
Figure 4‑53: Safety and Efficacy of Using PK Morcellator with Pneumoliner Containment Hysterectomy97
Figure 4‑54: Treatment of Missed Miscarriage with TRUCLEAR Tissue Removal System, a Feasibility Study97
Figure 4‑55: The Hysteroscopic Morcellator (HM)97
Figure 4‑56: Morcellator Versus Resectoscope in the Treatment of Uterine Polyps by Hysteroscopy (RESMO)98
Figure 4‑57: A Randomized Controlled Trial of Electrical Stimulation to Treat Pelvic Floor Disorder99
Figure 4‑58: A Study of Fractional Carbon Dioxide Laser Treatment for Female Stress Urinary Incontinence99
Figure 4‑59: Evaluation of the Safety and Efficacy of Carbon Dioxide (CO2) Acupulse Laser Treatment on Urinary Stress Incontinence99
Figure 4‑60: the Effect of a New Type of Pelvic Floor Rehabilitation Device PHENIX U4+ on the Treatment of Urinary Incontinence100
Figure 4‑61: Electrical Stimulation in Women with Pelvic Organ Prolapse100
Figure 4‑62: Carbon Dioxide Acupulse Laser Treatment Versus Sham Treatment and Stress Urinary Incontinence Symptoms100
Figure 4‑63: Effect of External Electrical Stimulation and Pelvic Floor Muscle Training101
Figure 4‑64: Comparison of the Efficacy of Sacrocolpopexy, the Amreich-Richter Procedure and Transvaginal Mesh (SAME)102
Figure 4‑65: Prospective Long-term Evaluation of the Efficacy and Safety of Calistar S for Transvaginal Pelvic Organ Prolapse Repair (CASPO)102
Figure 4‑66: SCP vs HUSLS for Pelvic Organ Prolapse Repair102
Figure 4‑67: Evaluation of Safety and Efficacy of the Apyx™ Device for the Repair of Pelvic Organ Prolapse (POP)103
Figure 4‑68: Restorelle® Mesh Versus Native Tissue Repair for Prolapse103
Figure 4‑69: Prospective Analysis of Restorelle in the Treatment of Uterine Prolapse103
Figure 4‑70: Analysis of Procedural Times Using Colpassist for Robotic-Assisted Sacrocolpopexy; a Randomized Controlled Trial (ACRAS)104
Figure 4‑71: Uterine Manipulator Versus no Uterine Manipulator in Endometrial Cancer Trial (MANEC)105
Figure 4‑72: Uterine Manipulator in Endometrial Cancer Surgery: Pro MUCEI Study (proMUCEI)105
Figure 4‑73: Pilot Trial of the Robotic Uterine Manipulator105
Figure 4‑74: Trial of YUMI Uterine Manipulator106
Figure 5‑1: Gynecological Market by Segment, U.S., 2019 – 2029 (US$M) (1 of 2)110
Figure 5‑2: Gynecological Market by Segment, U.S., 2019 – 2029 (US$M) (2 of 2)111
Figure 5‑3: Leading Competitors, Gynecological Device Market, U.S., 2022 (1 of 2)123
Figure 5‑4: Leading Competitors, Gynecological Device Market, U.S., 2022 (2 of 2)124
Figure 5‑5: SWOT Analysis, Boston Scientific139
Figure 5‑6: SWOT Analysis, Coloplast140
Figure 5‑7: SWOT Analysis, Cooper Surgical141
Figure 5‑8: SWOT Analysis, Hologic142
Figure 5‑9: SWOT Analysis, Laborie Medical143
Figure 5‑10: SWOT Analysis, Medtronic144
Figure 5‑11: SWOT Analysis, Merit Medical Systems145
Figure 5‑12: SWOT Analysis, Minerva Surgical146
Figure 5‑13: SWOT Analysis, Olympus147
Figure 5‑14: SWOT Analysis, Richard Wolf148
Figure 6‑1: Ovarian Cancer Incidence, U.S., 2019 – 2029150
Figure 6‑2: Pelvic Screens, U.S., 2019 – 2029151
Figure 6‑3: Procedure Codes Investigated152
Figure 6‑4: Gynecological Procedures by Type, U.S., 2019 – 2029 (1 of 2)154
Figure 6‑5: Gynecological Procedures by Type, U.S., 2019 – 2029 (2 of 2)155
Figure 6‑6: Fallopian Tube Procedures, U.S., 2019 – 2029157
Figure 6‑7: Assisted Reproduction Technology Procedures by Type, U.S., 2019 – 2029158
Figure 6‑8: Cervical Repair and Biopsy Procedures, U.S., 2019 – 2029159
Figure 6‑9: Global Endometrial Ablation Procedures by Modality, U.S., 2019 – 2029161
Figure 6‑10: Uterine Fibroid Embolization Procedures by Type, U.S., 2019 – 2029162
Figure 6‑11: Gynecological Endoscopy Procedures, U.S., 2019 – 2029164
Figure 6‑12: Morcellation Procedures by Type, U.S., 2019 – 2029166
Figure 6‑13: Vaginal Procedures, U.S., 2019 – 2029167
Figure 6‑14: Pelvic Organ Prolapse Procedures by Type, U.S., 2019 – 2029169
Figure 6‑15: HSG Catheter Procedures by Type, U.S., 2019 – 2029170
Figure 6‑16: Myomectomy Procedures, U.S., 2019 – 2029171
Figure 6‑17: Hysterectomy Procedures by Type, U.S., 2019 – 2029173
Figure 6‑18: Hysterectomy Procedures by Approach, U.S., 2019 – 2029175
Figure 7‑1: Assisted Reproduction Technology Device Market by Segment, U.S.,  2019 – 2029 (US$M)179
Figure 7‑2: Oocyte Retrieval Needle Market, U.S., 2019 – 2029181
Figure 7‑3: Micropipette Market by Segment, U.S., 2019 – 2029 (US$M)182
Figure 7‑4: Micropipette Market, U.S., 2019 – 2029183
Figure 7‑5: Flexible Pipette Market, U.S., 2019 – 2029184
Figure 7‑6: ICSI Pipette Market, U.S., 2019 – 2029185
Figure 7‑7: Embryo Transfer Catheter Market, U.S., 2019 – 2029186
Figure 7‑8: Reproduction Media Market by Segment, U.S., 2019 – 2029 (US$M)188
Figure 7‑9: Reproduction Media Market, U.S., 2019 – 2029189
Figure 7‑10: Culture Media Market, U.S., 2019 – 2029190
Figure 7‑11: Sperm Preparation Media Market, U.S., 2019 – 2029191
Figure 7‑12: Manipulation Media Market, U.S., 2019 – 2029192
Figure 7‑13: Freeze/Thaw Media Market, U.S., 2019 – 2029193
Figure 7‑14: Leading Competitors, Assisted Reproduction Technology Device Market, U.S., 2022197
Figure 8‑1: Global Endometrial Ablation Market by Segment, U.S., 2019 – 2029 (US$M)202
Figure 8‑2: Total Global Endometrial Ablation Market, U.S., 2019 – 2029204
Figure 8‑3: Thermal Ablation Device Market, U.S., 2019 – 2029205
Figure 8‑4: Hydrothermal Ablation Device Market, U.S., 2019 – 2029206
Figure 8‑5: Radiofrequency Ablation Device Market, U.S., 2019 – 2029207
Figure 8‑6: Cryoablation Device Market, U.S., 2019 – 2029208
Figure 8‑7: Leading Competitors, Global Endometrial Ablation Market, U.S., 2022212
Figure 9‑1: Uterine Fibroid Embolization Device Market by Segment, U.S.,  2019 – 2029 (US$M)217
Figure 9‑2: Microsphere Market, U.S., 2019 – 2029219
Figure 9‑3: PVA Particle Market, U.S., 2019 – 2029220
Figure 9‑4: Leading Competitors, Uterine Fibroid Embolization Device Market, U.S., 2022224
Figure 10‑1: Gynecological Endoscope Market, U.S., 2019 – 2029 (US$M)229
Figure 10‑2: Total Hysteroscope Market, U.S., 2019 – 2029232
Figure 10‑3: Total Reusable Hysteroscope Market, U.S., 2019 – 2029233
Figure 10‑4: Reusable Rigid Hysteroscope Market, U.S., 2019 – 2029234
Figure 10‑5: Reusable Flexible Hysteroscope Market by Segment, U.S., 2019 – 2029235
Figure 10‑6: Total Reusable Flexible Hysteroscope Market, U.S., 2019 – 2029236
Figure 10‑7: Video Flexible Hysteroscope Market, U.S., 2019 – 2029237
Figure 10‑8: Fiber Flexible Hysteroscope Market, U.S., 2019 – 2029238
Figure 10‑9: Disposable Hysteroscope Market, U.S., 2019 – 2029239
Figure 10‑10: Total Colposcope Market, U.S., 2019 – 2029240
Figure 10‑11: Colposcope Market by Segment, U.S., 2019 – 2029 (US$M)241
Figure 10‑12: Video Colposcope Market, U.S., 2019 – 2029242
Figure 10‑13: Non-Video Colposcope Market, U.S., 2019 – 2029243
Figure 10‑14: Resectoscope Market, U.S., 2019 – 2029244
Figure 10‑15: Leading Competitors, Gynecological Endoscope Market, U.S., 2022252
Figure 11‑1: Gynecological Electrosurgery Device Market by Segment, U.S., 2019 – 2029 (US$M)256
Figure 11‑2: Monopolar Loop Electrode Market, U.S., 2019 – 2029258
Figure 11‑3: Bipolar Loop Electrode Market, U.S., 2019 – 2029259
Figure 11‑4: Leading Competitors, Gynecological Resection Device Market, U.S., 2022263
Figure 12‑1: Morcellator Market by Segment, U.S., 2019 – 2029 (US$M)267
Figure 12‑2: Laparoscopic Morcellator Market, U.S., 2019 – 2029270
Figure 12‑3: Hysteroscopic Morcellator Market, U.S., 2019 – 2029272
Figure 12‑4: Leading Competitors, Morcellator Market, U.S., 2022276
Figure 13‑1: Pelvic Floor Electrical Stimulation Device Market by Segment, U.S.,  2019 – 2029 (US$M)281
Figure 13‑2: Home-Based PFES Device Market, U.S., 2019 – 2029284
Figure 13‑3: Office-Based PFES Device Market, U.S., 2019 – 2029285
Figure 13‑4: Leading Competitors, Pelvic Floor Electrical Stimulation Device Market, U.S., 2022290
Figure 14‑1: Fluid Management Device Market by Segment, U.S., 2019 – 2029 (US$M)294
Figure 14‑2: Fluid Management Equipment Market, U.S., 2019 – 2029296
Figure 14‑3: Fluid Management Tubing Market, U.S., 2019 – 2029297
Figure 14‑4: Leading Competitors, Fluid Management Device Market, U.S., 2022301
Figure 15‑1: Pelvic Organ Prolapse Repair Device Market by Segment, U.S., 2019 – 2029 (US$M)306
Figure 15‑2: Sacrocolpopexy Mesh Market, U.S., 2019 – 2029309
Figure 15‑3: Leading Competitors, Pelvic Organ Prolapse Repair Device Market, U.S., 2022313
Figure 16‑1: HSG Catheter Market, U.S., 2019 – 2029317
Figure 16‑2: Leading Competitors, HSG Catheter Market, U.S., 2022322
Figure 17‑1: Uterine Manipulator Market, U.S., 2019 – 2029325
Figure 17‑2: Leading Competitors, Uterine Manipulator Market, U.S., 2022329

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

  • 2023
  • 10 Years
  • United States
  • 2023-07-05
  • 332
  • MedSuite
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library